Suppr超能文献

作为铜绿假单胞菌细菌毒力因子LecB抑制剂的D-甘露糖肉桂酰胺衍生物

Cinnamide Derivatives of d-Mannose as Inhibitors of the Bacterial Virulence Factor LecB from Pseudomonas aeruginosa.

作者信息

Sommer Roman, Hauck Dirk, Varrot Annabelle, Wagner Stefanie, Audfray Aymeric, Prestel Andreas, Möller Heiko M, Imberty Anne, Titz Alexander

机构信息

Chemical Biology of Carbohydrates Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) Universitätsstrasse 1066123 Saarbrücken Germany; Department of Chemistry and Graduate School Chemical Biology University of Konstanz 78457 KonstanzGermany; Deutsches Zentrum für Infektionsforschung (DZIF) Inhoffenstraße 738124 Braunschweig Germany.

Centre de Recherche sur les Macromolécules Végétales (CERMAV-UPR5301) CNRS and Université Grenoble Alpes, BP53 38041 Grenoble cedex 9 France.

出版信息

ChemistryOpen. 2015 Oct 13;4(6):756-67. doi: 10.1002/open.201500162. eCollection 2015 Dec.

Abstract

Pseudomonas aeruginosa is an opportunistic Gram-negative pathogen with high antibiotic resistance. Its lectin LecB was identified as a virulence factor and is relevant in bacterial adhesion and biofilm formation. Inhibition of LecB with carbohydrate-based ligands results in a decrease in toxicity and biofilm formation. We recently discovered two classes of potent drug-like glycomimetic inhibitors, that is, sulfonamides and cinnamides of d-mannose. Here, we describe the chemical synthesis and biochemical evaluation of more than 20 derivatives with increased potency compared to the unsubstituted cinnamide. The structure-activity relationship (SAR) obtained and the extended biophysical characterization allowed the experimental determination of the binding mode of these cinnamides with LecB. The established surface binding mode now allows future rational structure-based drug design. Importantly, all glycomimetics tested showed extended receptor residence times with half-lives in the 5-20 min range, a prerequisite for therapeutic application. Thus, the glycomimetics described here provide an excellent basis for future development of anti-infectives against this multidrug-resistant pathogen.

摘要

铜绿假单胞菌是一种具有高抗生素耐药性的机会性革兰氏阴性病原体。其凝集素LecB被鉴定为一种毒力因子,与细菌粘附和生物膜形成有关。用基于碳水化合物的配体抑制LecB会导致毒性和生物膜形成减少。我们最近发现了两类有效的类药物糖模拟抑制剂,即D-甘露糖的磺酰胺和肉桂酰胺。在此,我们描述了20多种衍生物的化学合成和生化评估,这些衍生物的效力比未取代的肉桂酰胺有所提高。获得的构效关系(SAR)和扩展的生物物理表征使得能够通过实验确定这些肉桂酰胺与LecB的结合模式。已确定的表面结合模式现在为未来基于合理结构的药物设计提供了可能。重要的是,所有测试的糖模拟物都显示出延长的受体驻留时间,半衰期在5-20分钟范围内,这是治疗应用的一个前提条件。因此,本文所述的糖模拟物为未来开发针对这种多重耐药病原体的抗感染药物提供了极好的基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7901/4906503/f6e3b26c81af/OPEN-4-756-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验